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The lipid organization in the upper layer of the skin, the stratum corneum (SC), is important for the skin barrier
function. This lipid organization, including the characteristic 13 nm lamellar phase, can be reproduced in vitro with
mixtures based on cholesterol, free fatty acids and natural as well as synthetic ceramides (CER). In human SC, nine
CER classes have been identiﬁed (CER1–CER9). Detailed studies on the effect of molecular structure of individual
ceramides on the SC lipid organization are only possible with synthetic lipid mixtures, as their composition can be
accurately chosen and systematically modiﬁed. In the present study, small-angle X-ray diffraction was used to
examine the organization in synthetic lipid mixtures of which the synthetic ceramide fraction was prepared with
sphingosine-based CER1 or phytosphingosine-based CER9. The latter acylceramide contains an additional hy-
droxyl group at the sphingoid backbone. The results show that a gradual increase in CER1 level consistently
promotes the formation of the 13 nm lamellar phase and that partial replacement of CER1 by CER9 does not affect
the phase behavior. Interestingly, complete substitution of CER1 with CER9 reduces the formation of the long
periodicity phase and results in phase separation of CER9.
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Ceramides (CER), cholesterol (CHOL), and long-chain free
fatty acids (FFA) are the most abundant lipid species
present in the stratum corneum (SC) and are responsible
for proper function of the skin barrier. Human SC contains at
least nine extractable CER types (Wertz et al, 1985; Robson
et al, 1994; Stewart and Downing, 1999; Ponec et al, 2003),
classified as CER1 to CER9. The molecular structures of the
CER are illustrated in Fig S1. The CER can be subdivided
into three main groups, based on the nature of their back-
bone (sphingosine (S), phytosphingosine (P) and 6-hydro-
xysphingosine (H)). Through an amide bonding, long-chain
non-hydroxy (N) or a-hydroxy (A) fatty acids with varying
acyl chain lengths are chemically linked to the sphingosine
bases. The acylceramides CER1 (EOS), CER4 (EOH), and
the recently identified CER9 (EOP) are unique in structure as
they contain linoleic acid linked to an o-hydroxy fatty acid
(EO) with a chain length of 30–32 carbon atoms.
X-ray diffraction studies demonstrated the presence of
two co-existing lamellar phases in human SC: the short
periodicity phase (SPP) with a repeat distance of approx-
imately 6 nm and the long periodicity phase (LPP) with a
repeat distance of approximately 13 nm (Bouwstra et al,
1991a, b, 1995). The molecular organization of the LPP to-
gether with its predominantly orthorhombic lipid packing in
the presence of substantial amounts of CHOL are excep-
tional and are therefore considered to play an important role
in the skin barrier function (Bouwstra et al, 2002).
X-ray diffraction studies on lipid mixtures prepared with
CHOL, FFA, and CER isolated from human or pig SC
(natCER (natural ceramides)) revealed that the lipid organ-
ization in these mixtures closely mimics that observed in
native SC. These studies have markedly contributed to our
present knowledge on the SC lipid organization and the role
the main lipid classes play in the SC lipid organization
(Bouwstra et al, 1996, 2001; McIntosh et al, 1996). The role
of the head group architecture or acyl chain length on the
lipid phase behavior, however, cannot be studied using
natCER mixtures, as it is impossible to isolate the individual
CER subclasses in large quantities. For this reason, we de-
cided to investigate the lipid organization in mixtures pre-
pared with synthetic ceramides (synthCER), which offers
the possibility to substitute one single ceramide subclass
for another one. A first prerequisite, however, for the pos-
sibility to use synthCER is that their phase behavior reflects
that observed in SC. In previous studies, we have demon-
strated that the SC lipid organization can be reproduced to
a high extent with equimolar mixtures of CHOL, FFA, and a
limited number of synthCER, namely CER1, CER3, and bo-
vine brain CER type IV (referred to as SCERIV) mixed in
a 1:7:2 molar ratio, provided that an appropriate equili-
brium temperature is chosen during sample preparation (de
Jager et al, 2004a,b). In synthetic CER1 and CER3,
non-hydroxy fatty acids of a uniform acyl chain length are
linked to the (phyto)sphingoid backbone, whereas the
sphingosine-based SCERIV contains a-hydoxy fatty acids
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with varying acyl chain lengths, with C18 (22%) and C24
(42%) as the most abundantly present (de Jager et al,
2004b). For achievement of a similar lipid organization as
observed in the SC, the presence of FFA and an optimal ratio
of CER3 and SCERIV are crucial (de Jager et al, 2004b).
The present study focuses on the role the head group
architecture of the acylceramides plays on the phase be-
havior of synthetic lipid mixtures. In human SC, approxi-
mately 8.3% of the total CER fraction comprises CER1
(sphingosine base), whereas CER9 (phytosphingosine base)
accounts for 6.4% (Ponec et al, 2003). For this reason, we
studied synthCER mixtures containing only one acylcer-
amide (CER1 or CER9) as well as mixtures in which both
acylceramides are present, by partially substituting CER1
with CER9. The use of CER9 with an o-hydroxy fatty acid
chain length of either 30 or 27 carbon atoms also allowed
us to study the role of the acyl chain length on the lipid
organization. The major finding of the present study is that
partial replacement of CER1 by CER9 does not affect the
lipid organization, whereas complete substitution of CER1
with CER9 inhibits the formation of the LPP and results in
phase separation of CER9.
Results
LPP is formed in equimolar CHOL:synthCER:FFA mix-
tures prepared with CER1 or CER9 The diffraction pattern
of a CHOL:[CER1:CER3:SCERIV]:FFA mixture prepared at a
molar ratio of 1:[0.1:0.7:0.2] is shown in Fig 1A. The LPP with
a repeat distance of 12.2 nm is indicated by the presence
of six reflections (q¼0.52, 1.03, 1.54, 2.06, 3.08, and
3.59 nm1). The reflections at q¼1.16 and 2.33 nm1 cor-
respond to the first and second order diffraction peaks of a
lamellar phase with a periodicity of 5.4 nm (SPP). The two
strong reflections at 1.71 and 3.43 nm1 reveal the presence
of a phase with a periodicity of 3.7 nm, ascribed to crys-
talline CER3 in a V-shaped formation (Dahlen and Pascher,
1979; de Jager et al, 2003; Raudenkolb et al, 2003). The
presence of crystalline CHOL in separate domains can be
deduced from the peaks at 1.87 and 3.74 nm1.
Complete substitution of CER1 with CER9(C30) results in
the diffraction pattern depicted in Fig 1A. Obviously, the
LPP with a repeat distance of 12.1 nm is also formed in the
presence of CER9(C30), although the intensities of its re-
flections in comparison with the SPP reflections are weaker
than observed in the CER1-containing mixture. A weak
reflection at 0.70 nm1 suggests that a small fraction
of CER9(C30) phase separates (see the next section for
a more detailed description of this phase). In addition, crys-
talline CHOL and CER3 in a V-shaped formation are present
in the lipid mixture.
Replacement of CER9(C30) with CER9(C27) in the mix-
ture results in a marked reduction of LPP formation (data
not shown). In addition, the repeat distance of this phase
shifts to 11.7 nm. The formation of the other above-men-
tioned phases is not affected by the reduced o-hydroxy
fatty acid chain length of CER9(C27).
LPP is not formed in mixtures prepared with CER9 in the
absence of FFA Figure 1B shows the diffraction pattern of
the equimolar CHOL:synthCER mixture, prepared at a 1:7:2
ratio of CER1, CER3, and SCERIV. Five equidistant peaks
suggest the presence of the LPP (12.2 nm), whereas the
SPP (5.3 nm) is indicated by two reflections. In addition,
phase-separated CER3 and CHOL can be detected. Com-
pared with the diffraction curve of the equimolar CHOL:
synthCER:FFA mixture prepared with CER1, the intensities
of the reflections attributed to the LPP and SPP decreased
as compared with those of crystalline CER3 and CHOL.
Complete substitution of CER1 with CER9(C30) results in
the diffraction pattern depicted in Fig 1B. Compared with
the mixture containing CER1, three major changes are ob-
served in the presence of CER9(C30): (i) No reflections can
be detected that might be ascribed to the LPP, indicating
that no LPP is formed. (ii) Four reflections at 0.70, 1.41,
2.10, and 2.79 nm1 reveal the presence of a phase with a
repeat distance of 9.0 nm. This corresponds to the length of
two opposing CER9(C30) molecules in a hairpin formation
and is similar to the repeat distance found for hydrated
pig CER1 (McIntosh et al, 1996). Taking into account the
diffraction patterns depicted in Fig 2B (see below), it is
Figure 1
Free fatty acids (FFA) promote long periodicity
phase (LPP) formation in mixtures containing
10% ceramide (CER)1 or 10% CER9. The inset
is a magnification of the reflections in the q-range
between 2 and 4 nm1. The Arabic and Roman
numbers indicate the diffraction orders of the LPP
and short periodicity phase (SPP), respectively.
C3 refers to the reflections of crystalline CER3
located at 1.71 and 3.42 nm1, whereas C9 refers
to the reflections of crystalline CER9 located at
0.70, 1.41, 2.10, and 2.79 nm1. The asterisk ()
indicates the reflections of crystalline cholesterol
(CHOL) located at 1.87 and 3.74 nm1. (A) Dif-
fraction patterns of CHOL:synthCER:FFA mix-
tures prepared with CER1 or CER9. The various
orders of the LPP are located at q¼ 0.52 nm1
(1), 1.03 nm1 (2), 1.56 nm1 (3), 2.08 nm1 (4),
3.09 nm1 (6), and 3.56 nm1 (7). The various
orders of the SPP are located at q¼1.17 nm1 (I) and 2.34 nm1 (II). (B) Diffraction patterns of CHOL:synthCER mixtures prepared with CER1 or
CER9. The various orders of the LPP are located at q¼0.52 nm1 (first), 1.03 nm1 (second), 1.56 nm1 (3), 2.08 nm1 (4), and 3.09 nm1 (6). The
various orders of the SPP are located at q¼ 1.17 nm1 (1) and 3.51 nm1 (III). (B)
912 DE JAGER ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
conceivable to assign this phase to crystalline CER9(C30)
in separate domains. (iii) The 3.7 nm phase, attributed
to crystalline CER3, is not present. Instead, a shoulder at
1.57 nm1 might designate the presence of a new phase
with a periodicity of 4.0 nm. No higher-order reflections,
however, can be detected. The exact composition and na-
ture of this phase is not known.
The diffraction pattern of the mixture containing
CER9(C27) is almost identical to the one obtained with
CER9(C30) (data not shown). No LPP is present in the mix-
ture and several reflections indicate the presence of a phase
with a repeat distance of 8.7 nm, ascribed to phase-sep-
arated CER9. The slightly shorter periodicity of this phase
can be explained by the shorter o-hydroxy fatty acid chain
length of CER9(C27).
LPP formation in equimolar CHOL:synthCER:FFA mix-
tures depends on acylceramide content To assess the
effect of the relative acylceramide content on the lipid or-
ganization in equimolar mixtures of CHOL, synthCER, and
FFA, the amount of CER1 or CER9 in the synthCER fraction
was gradually increased from 0% to 20% mol per mol,
thereby maintaining the ratio between CER3 and SCERIV
constant. As CER9(C27) is less effective in promoting the
formation of the LPP, these experiments were only per-
formed with CER1 and CER9(C30). Below, the changes in
lipid organization as a function of acylceramide type and
relative amount are presented.
In the absence of CER1 and CER9, the characteristic
LPP is not present (data not shown). Instead, three strong
reflections indicate the presence of a 5.4 nm lamellar phase
(SPP). In addition, crystalline CER3 and CHOL are present
in the mixture, both indicated by two reflections.
In the equimolar CHOL:synthCER:FFA mixture in which
the synthCER fraction contains 5% CER1, only a small
fraction of lipids forms the LPP, as deduced from the pres-
ence of four weak reflections in the diffraction pattern (see
Fig 2A). The diffraction curve of the mixture prepared with
10% CER1 is illustrated in Fig 1A (see the previous section
for a more detailed description of the phases present). Ev-
idently, the fraction of lipids that forms the LPP increased. A
raise in CER1 content to 15% or 20% results in diffraction
patterns in which the intensities of the LPP reflections fur-
ther increase as compared with the peak intensities of the
SPP, CER3 and CHOL. Even in the presence of 20% CER1
(see Fig 2A), no peaks can be detected that might be as-
cribed to crystalline CER1 in separate domains.
The diffraction pattern of the equimolar CHOL:synth-
CER:FFA mixture of which the synthCER fraction contains
5% CER9 (see Fig 2B) is similar to the one obtained with 5%
CER1. The majority of lipids forms the SPP, although weak
reflections indicate that a minute fraction of lipids forms a
phase with a periodicity of 12.0 nm. In addition, crystalline
CER3 and CHOL are present in the mixture. The diffraction
curve of the mixture prepared with 10% CER9 (see Fig 1A)
has already been explained in the previous section. At this
concentration, the LPP is clearly present and a small frac-
tion of CER9 phase separates. When the amount of CER9 in
the synthCER fraction is further raised to 15% or 20% (see
Fig 2B), some striking changes in the lipid organization are
observed: (i) The reflections attributed to the LPP markedly
reduce in intensity as compared with the peak intensities of
the other phases. Moreover, only the first three order dif-
fraction peaks of the LPP can be detected. This indicates
that at increased CER9 content, the formation of the LPP is
inhibited. (ii) An increased amount of CER9 phase separates
into separate domains, indicated by strong reflections at
q¼0.70, 1.40, 2.10, and 2.80 nm1, which reveal the pres-
ence of a 9.0 nm phase. (iii) The reflections ascribed to
phase-separated CER3, which is present at a CER9 level of
5% and 10%, completely disappear when the amount of
CER9 in the mixture is increased.
No change in LPP formation upon partial substitution
of CER1 with CER9 in equimolar CHOL:synthCER:FFA
mixtures As native SC contains both CER1 (8.3%) and
CER9 (6.4%), we also prepared lipid mixtures in which both
acylceramides were present in ratios similar to that found in
human SC. The mixtures were prepared with a synthCER
fraction that contained 5% CER1 and 10% CER9 and vice
versa, thereby maintaining the ratio between CER3 and
SCERIV constant. In both mixtures, six diffraction peaks
Figure 2
Long periodicity phase (LPP) formation in equi-
molar cholesterol (CHOL): synthetic ceramides
(synthCER): free fatty acids (FFA) mixtures de-
pends on acylceramide content. The inset is a
magnification of the reflections in the q-range be-
tween 2 and 4 nm1. The Arabic and Roman num-
bers indicate the diffraction orders of the LPP and
short periodicity phase (SPP), respectively. C3 re-
fers to the reflections of crystalline CER3 located at
1.71 and 3.42 nm1, whereas C9 refers to the re-
flections of crystalline ceramide (CER)9 located at
0.70, 1.40, 2.10, and 2.80 nm1. The asterisk ()
indicates the reflections of crystalline CHOL locat-
ed at 1.87 and 3.74 nm1. (A) Diffraction patterns
of CHOL:synthCER:FFA mixtures prepared with 5
and 20% CER1. The various orders of the LPP are
located at q¼ 0.52 nm1 (1), 1.03 nm1 (2), 1.56
nm1 (3), 2.08 nm1 (4), 3.09 nm1 (6), and 3.56
nm1 (4). The various orders of the SPP are located at q¼ 1.17 nm1 (I) and 234 nm1 (II). (B) Diffraction patterns of CHOL:synthCER:FFA mixtures
prepared with 5 and 20% CER9. The various orders of the LPP are located at q¼0.52 nm1 (1), 1.03 nm1 (2), and 1.56 nm1 (3). The various orders
of the SPP are located at q¼ 1.17 nm1 (I), 2.34 nm1 (II), and 3.51 nm1 (III).
LIPID ORGANIZATION IN SYNTHETIC CERAMIDE MIXTURES 913123 : 5 NOVEMBER 2004
clearly indicate the presence of the LPP, whereas the SPP is
identified by two diffraction peaks (see Fig 3). In addition,
crystalline CER3 and CHOL are present. The relative in-
tensities of the reflections attributed to the various phases in
both diffraction patterns are similar. Moreover, the diffrac-
tion patterns resemble closely the one obtained with the
mixture prepared with 15% CER1.
Discussion
In human SC, approximately 8.3% of the total CER fraction
comprises CER1, whereas CER4 and CER9 account for
5.0% and 6.4%, respectively (Ponec et al, 2003). From
the studies performed with mixtures based on natCER, we
know that CER1 plays a prominent role in the formation of
the LPP, characteristic for the SC lipid phase behavior. After
the exclusion of CER1 from mixtures prepared with CER
isolated from human SC, still a small fraction of lipids forms
the LPP (Bouwstra et al, 2001). This indicates that CER4 or
CER9 or both contribute to a certain extent to the formation
of the LPP. Until now, however, the role CER4 and CER9
play in the lipid organization could not be studied, as it
is impossible to isolate these acylceramides in sufficient
quantities from human SC. As we now have available syn-
thetic CER9, this is the first study in which we could
systematically study the role of CER9, and CER9 in com-
bination with CER1 on the lipid organization. Several im-
portant features were noticed: (i) CER1 promotes the
formation of the LPP to a higher extent than CER9. (ii) The
maximum solubility of CER9 in the lipid lamellar phases is
lower than that of CER1. (iii) CER1 promotes incorporation
of CER9 into the lamellar phases.
What can we learn from these observations? The pres-
ence of an additional hydroxyl group at the sphingoid base
of acylceramides impedes the formation of the LPP. This is
specially observed in equimolar CHOL:synthCER mixtures
in which CER9 is not able to induce the formation of the
LPP. Instead, strong reflections in the diffraction pattern re-
veal the presence of crystalline CER9 in separate domains.
A possible explanation for this finding is that the larger and
more hydrophilic head group present in CER9 inhibits the
formation of the LPP. The situation changes when FFA were
added to the CHOL:synthCER mixtures: Phase separation
of CER9 is reduced and the LPP is formed. Unlike the
synthCER fraction, the FFA fraction shows a high variation
in acyl chain lengths. This may suggest that incorporation of
CER9 into the lamellar phases in synthetic lipid mixtures
requires the presence of acyl chains with varying lengths.
Additional studies with mixtures prepared with FFA of a
uniform chain length, however, should be performed to elu-
cidate this. Furthermore, it needs to be emphasized, that
the simplified synthetic lipid mixtures used might be more
sensitive to phase separation than natCER present in native
SC, due to limited variability in head group architecture and
acyl chain length in the synthCER fraction.
Interestingly, the chain length of the o-hydroxy acid in
CER9 seems to have a major influence on the lamellar or-
dering of the lipids, as CER9(C27) is less effective in pro-
moting the formation of the LPP than CER9(C30). Possibly,
the presence of a shorter o-hydroxy acid in CER9(C27) is
less efficient in spanning the two broad lipid layers within
the suggested tri-layer unit of the LPP (Bouwstra et al,
1998). This might result in a reduced stability of the LPP and
a shift of the repeat distance to lower values (11.7 nm).
Another difference observed between CER1 and CER9 is
the dependence of the formation of the LPP on the acylcer-
amide level. Although a raise in CER1 content from 0% to
20% leads to a consistent enhancement of the LPP forma-
tion, a more complex phase behavior is observed in mix-
tures prepared with CER9. There, a raise in CER9 content
up to 10% promotes the formation of the LPP. A further
raise in the CER9 content reduces the formation of the LPP
and results in the formation of crystalline CER9 in separate
domains. Phase separation of CER9 is already observed in
mixtures in which the synthCER fraction is prepared with
10% CER9. This means that even in the presence of FFA,
the amount of CER9 that can be incorporated into the LPP
is limited.
The findings that only a minute fraction of lipids organ-
izes into the LPP when the synthCER fraction contains 5%
CER9 and that no LPP is present in the absence of CER1
and CER9 confirm and extend the previous results obtained
with mixtures prepared with natCER (Bouwstra et al, 2001).
Based on the results of the present study, we can speculate
that CER9 is indeed able to promote the formation the LPP
Figure 3
No substantial change in lipid organization in cholesterol (CHOL):
synthetic ceramides (synthCER):free fatty acids (FFA) mixtures in
which CER1 is partially substituted with CER9. The inset is a mag-
nification of the reflections in the q-range between 2 and 4 nm1. The
Arabic and Roman numbers indicate the diffraction orders of the long
periodicity phase (LPP) and short periodicity phase (SPP), respectively.
C3 refers to the reflections of crystalline CER3 located at 1.71 and 3.42
nm1. The asterisk () indicates the reflections of crystalline CHOL lo-
cated at 1.87 and 3.74 nm1. The various orders of the LPP are located
at q¼ 0.52 nm1 (1), 1.03 nm1 (2), 1.56 nm1 (3), 2.08 nm1 (4), 3.09
nm1 (6), and 3.56 nm1 (7). The various orders of the SPP are located
at q¼ 1.17 nm1 (I) and 2.34 nm1 (II).
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in natCER mixtures, which are excluded from CER1. From
our results, however, we cannot deduce whether the relative
amount of CER9 present in the SC is insufficient to effec-
tively promote the formation of the LPP or that its larger and
more hydrophilic head group hampers the formation of the
LPP. Although the differences in phase behavior between
CER1 and CER9 in synthCER mixtures are much more pro-
nounced at increased acylceramide levels, CER1, always,
more effectively promotes the formation of the LPP than
CER9, even at a relative amount of 5%. The question
whether CER4, which contains a 6-hydroxysphingosine
head group that is even larger than the phytosphingosine
head group of CER9, is also able to promote the formation
of the LPP remains unanswered.
In spite of the finding that CER9 is less efficient in en-
hancing the formation of the LPP than CER1, partial sub-
stitution of CER1 with CER9 does not significantly affect the
lipid organization. When extrapolating these findings to
the in vivo situation, one can expect that small variations
in the relative content of individual acylceramides will not
substantially change the SC lipid organization. The situa-
tion, however, is usually more complex in vivo. In lamellar
ichthyosis and atopic dermatitis, a marked reduction in
CER1 in the lesion parts of the SC is observed (Yamamoto
et al, 1991; Lavrijsen et al, 1995; Di Nardo et al, 1998; Bleck
et al, 1999). In addition, in various skin disorders simulta-
neous changes in composition and content of various lipid
classes are observed. All these changes may explain the
reduced LPP formation in these skin disorders.
In conclusion, lipid mixtures prepared with synthCER of-
fer an attractive tool to unravel the importance of molecular
structure of individual CER on the SC lipid organization. The
primary finding of the present study is that the head group
architecture of acylceramides considerably affects the lipid
organization. Compared with CER1, containing a sphingo-
sine base, CER9 with its phytosphingosine base is less ef-
ficient in promoting the formation of the characteristic LPP
and the level CER9 in the LPP is limited.
Materials and Methods
Materials Palmitic acid, stearic acid, arachidic acid, behenic acid,
tricosanoic acid, lignoceric acid, cerotic acid, CHOL, and bovine
brain ceramide type IV were purchased from Sigma-Aldrich
Chemie GmbH (Schnelldorf, Germany). N-(30-linoleoyloxy-triacon-
tanoyl)-sphingosine (synthetic ceramide 1(C30)-linoleate), N-(30-
linoleoyloxy-triacontanoyl)-phytosphingosine (synthetic ceramide
9(C30)-linoleate), N-(27-linoleyl-heptacosanoyl)-phytosphingosine
(synthetic ceramide 9(C27)-linoleate), and N-Tetracosanoyl-phyto-
sphingosine (synthetic ceramide 3(C24)) were generously provided
by Cosmoferm B.V. (Delft, The Netherlands). All organic solvents
used were of analytical grade and manufactured by Labscan
(Dublin, Ireland).
Preparation of the lipid mixtures For the preparation of the
CHOL:synthCER:FFA mixtures, the following fatty acid mixture was
used: C16:0, C18:0, C20:0, C22:0, C23:0, C24:0, and C26:0 at
molar ratios of 1.3, 3.3, 6.7, 41.7, 5.4, 36.8, and 4.7, respectively.
This is similar to the FFA ratio found in SC (Wertz and Downing,
1991). Appropriate amounts of individual lipids dissolved in chlo-
roform:methanol (2:1) were combined to yield mixtures of approx-
imately 1.5 mg dry weight at the desired composition with a total
lipid concentration of 7 mg per mL. A Camag Linomat IV (CAMAG,
Muttenz, Switzerland) was used to spray the lipid mixtures onto
mica. This was done at a rate of 4.3 mL per min under a continuous
nitrogen stream. The samples were equilibrated for 10 min at 801C
(CHOL:synthCER:FFA) or 951C (CHOL:synthCER) and subsequent-
ly hydrated with an acetate buffer of pH 5.0. Finally, the samples
were homogenized by 10 successive freeze–thawing cycles be-
tween 201C and room temperature, during which the samples
were stored under gaseous argon.
Small-angle X-ray diffraction (SAXD) All measurements were
performed at the European Synchrotron Radiation Facility (ESRF,
Grenoble) using station BM26B (Bras, 1998). The X-ray wavelength
and the sample-to-detector distance were 1.24 A˚ and 1.7 m, re-
spectively. Diffraction data were collected on a two-dimensional
multiwire gas-filled area detector. The spatial calibration of this
detector was performed using silver behenate. The samples were
mounted in a sample holder with mica windows. Diffraction pat-
terns of the lipid mixtures were obtained at room temperature for
a period of 5 min. All measurements were performed at least in
duplicate during two different sessions.
Small angle X-ray diffraction provides information about the
larger structural units in the sample, namely the repeat distance of
a lamellar phase. The scattering intensity I (in arbitrary units) was
measured as a function of the scattering vector q (in reciprocal
nm). The latter is defined as q¼ (4psiny)/l, in which y is the scat-
tering angle and l is the wavelength. From the positions of a series
of equidistant peaks (qn), the periodicity, or d-spacing, of a lamellar
phase was calculated using the equation qn¼ 2np/d, n being the
order number of the diffraction peak. The Leiden/Amsterdam
Center for Drug Research of the University of Leiden approved all
described studies.
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The following material is available from http://www.blackwellpublishing.
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Figure S1
The molecular structures of the ceramide (CER) present in human
stratum corneum (SC). Two nomenclatures systems are given. The
numbering system is based on chromatographic migration, whereas
the other system (introduced by Motta et al, 1993) is based on the
molecular structure.
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